Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002585038 | SCV003489288 | likely benign | Nemaline myopathy 2 | 2023-07-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004073386 | SCV004979166 | uncertain significance | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | The c.4354A>C (p.I1452L) alteration is located in exon 38 (coding exon 36) of the NEB gene. This alteration results from a A to C substitution at nucleotide position 4354, causing the isoleucine (I) at amino acid position 1452 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |